Medical University of Silesia

🇵🇱Poland

Country: 🇵🇱Poland

Ownership: Private

Established: 1948-03-20

Employees: -

Market Cap: -

Website: http://www.smk.sum.edu.pl

Clinical Trials

Biologics and Sublingual Immunotherapy

Phase 4

Not yet recruiting

Conditions: Asthma, Allergic

Interventions: Biological: omalizumab

First Posted Date: 2023-09-07

Last Posted Date: 2023-09-07

Lead Sponsor: Medical University of Silesia

Target Recruit Count: 150

Registration Number: NCT06027073

Physiologic Cardiac Pacing to Prevent Left Ventricular Dysfunction Post TAVI

Not Applicable

Not yet recruiting

Conditions: Atrioventricular Block, Second and Third Degree

Interventions: Device: conduction system pacing
Device: right ventricular or biventricular pacing

First Posted Date: 2023-08-01

Last Posted Date: 2023-08-08

Lead Sponsor: Medical University of Silesia

Target Recruit Count: 500

Registration Number: NCT05966675

Locations: 🇵🇱
Medical University of Silesia in Katowice, Katowice, Poland

Effectiveness, Complications, and Mortality of TLE in Patients.

Completed

Conditions: Transvenous Lead Extraction

Interventions: Procedure: Transvenous lead extraction

First Posted Date: 2023-03-20

Last Posted Date: 2023-03-20

Lead Sponsor: Medical University of Silesia

Target Recruit Count: 504

Registration Number: NCT05775783

Locations: 🇵🇱
Krzysztof Gołba, Katowice, Poland

Vasopressor Support, Mean Arterial Pressure and Capillary Refill Time in Critically Ill Patients

Recruiting

Conditions: Critical Illness

Interventions: Diagnostic Test: Capillary refill time

First Posted Date: 2023-01-06

Last Posted Date: 2023-01-06

Lead Sponsor: Medical University of Silesia

Target Recruit Count: 150

Registration Number: NCT05674084

Locations: 🇵🇱
University Clinical Center named after prof. K. Gibiński of the Medical University of Silesia in Katowice, Katowice, Silesia, Poland

NIV-FOB, HFNC-FOB- Comparison of Methods

Not Applicable

Conditions: Hypoxemic Respiratory Failure
Hypoxemia
Respiratory Failure

Interventions: Device: NIV, HFNO

First Posted Date: 2022-12-16

Last Posted Date: 2022-12-16

Lead Sponsor: Medical University of Silesia

Target Recruit Count: 300

Registration Number: NCT05655026

Locations: 🇵🇱
Aleksandra, Katowice, Poland

May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases?

Not Applicable

Recruiting

Conditions: Interstitial Lung Disease
Chronic Obstructive Pulmonary Disease

Interventions: Procedure: BAL + PAP

First Posted Date: 2022-11-30

Last Posted Date: 2023-09-07

Lead Sponsor: Medical University of Silesia

Target Recruit Count: 100

Registration Number: NCT05631132

Locations: 🇵🇱
Pulmunology Department, Katowice, Poland

Cardiovascular Disease in Patients With Diabetes: The Silesia Diabetes-Heart Project

Recruiting

Conditions: Diabetes Mellitus

First Posted Date: 2022-11-23

Last Posted Date: 2024-04-10

Lead Sponsor: Medical University of Silesia

Target Recruit Count: 4000

Registration Number: NCT05626413

Locations: 🇵🇱
Department of Internal Diseases, Diabetology and Nephrology, Zabrze, Poland

CBD (Cannabidiol) Intraoral Application and TMD (Temporomandibular Disorders)

Phase 2

Recruiting

Conditions: Temporomandibular Disorder
Bruxism
Myofascial Pain
CBD
Orofacial Pain

Interventions: Combination Product: 10% polymer gel with CBD application
Combination Product: 5% polymer gel with CBD application
Combination Product: Placebo intervention

First Posted Date: 2022-10-03

Last Posted Date: 2023-07-21

Lead Sponsor: Medical University of Silesia

Target Recruit Count: 30

Registration Number: NCT05562635

Locations: 🇵🇱
Department of TMD, Zabrze, Poland

Neurogenic Myocardial and Lung Injury in SAH Patients

Recruiting

Conditions: Lung Injury
Myocardial Injury
Subarachnoid Hemorrhage

Interventions: Diagnostic Test: hs-TnT (high-sensitive cardiac troponin T) plasma concentration
Diagnostic Test: CK-MB (creatine kinase myocardial band) plasma concentration
Diagnostic Test: CPK (creatine phosphokinase) plasma concentration
Diagnostic Test: NT-proBNP (N-terminal prohormone of brain natriuretic peptide) plasma concentration
Diagnostic Test: Metanephrine concentration in urine

First Posted Date: 2022-06-07

Last Posted Date: 2023-05-06

Lead Sponsor: Medical University of Silesia

Target Recruit Count: 30

Registration Number: NCT05408988

Locations: 🇵🇱
University Clinical Center prof. K. Gibiński of the Medical University of Silesia in Katowice, Katowice, Województwo Śląskie, Poland

The Assessment of Immune Response in Newly Diagnosed Glioblastoma Patients Treated With Pembrolizumab

Phase 4

Recruiting

Conditions: Newly Diagnosed Glioblastoma

Interventions: Drug: Pembrolizumab

First Posted Date: 2022-02-11

Last Posted Date: 2023-08-31

Lead Sponsor: Medical University of Silesia

Target Recruit Count: 36

Registration Number: NCT05235737

Locations: 🇵🇱
Wojciech Kaspera, Sosnowiec, Silesian, Poland

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy